<div style="width: 100%; height: 500px; margin: 20px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; position: relative; z-index: 1;">
    <iframe 
        src="https://s.tradingview.com/widgetembed/?symbol=LLY&interval=D&theme=Light&style=1&locale=en&toolbarbg=f1f3f6&hideideas=1&studies=%5B%22MASimple%40tv-basicstudies%22%2C%20%22MACD%40tv-basicstudies%22%5D" 
        style="width: 100%; height: 100%; border: 0; display: block;" 
        scrolling="no" 
        allowtransparency="true" 
        frameborder="0">
    </iframe>
</div>

📊 TECHNICAL DEEP DIVE (Multi-Timeframe Analysis) A. TREND STRUCTURE (The "Big Picture") - MA System: The price is above both the Weekly MA20 (1071.09) and the Daily MA20 (1075.79), indicating a Bullish major trend. - Bollinger Bands: The price is not breaking the Upper Band, but the Band Width is 5.57 on the daily chart and 2.13 on the intraday chart, suggesting some volatility. B. MOMENTUM & MONEY FLOW (The "Engine") - MACD: The Weekly MACD Histogram is 14.584 (Positive), while the Daily MACD Histogram is -2.991 (Negative), indicating some fading momentum on the Daily chart. The intraday MACD Histogram is 0.283 (Positive), showing weakening momentum. - RSI & KDJ: The Daily RSI(14) is 55.24 (Neutral), and the intraday RSI(14) is 48.85 (Neutral). The KDJ (J) is 50.01 on the daily chart and 48.82 on the intraday chart, indicating no clear trend reversal. - OBV (Volume): Not provided, but the ATR (Volatility) is 30.01 on the daily chart and 9.57 on the intraday chart, suggesting moderate volatility. - ATR (Volatility): As mentioned, the ATR is 30.01 on the daily chart and 9.57 on the intraday chart. C. VERDICT: The technical outlook is Bullish, but with some signs of fading momentum on the Daily chart. 🎯 QUANT SCORE (2-4 Weeks View) [LONG SCORE: 60] [SHORT SCORE: 40] 🚀 STRATEGY & RISK MANAGEMENT - Action: Enter. - Levels: Support at 1041.25 (Lower Bollinger Band) and Resistance at 1100.93 (Upper Bollinger Band). - Option Play: With moderate volatility, a Buy Call Options strategy could be considered. 🧐 ASSET PROFILE (Fundamental Context) - Identity: Eli Lilly (LLY) is a pharmaceutical company that discovers, develops, manufactures, and markets human pharmaceutical products. - Status/Holdings: As a leading pharmaceutical company, Eli Lilly has a strong industry position. - Business Model: Eli Lilly's business model is focused on the research, development, and commercialization of pharmaceutical products, with a diverse portfolio of medicines across various therapeutic areas. - Recent Profitability/Earnings Trend: The company has shown a Net Income growth trend, driven by the success of its key products and a strong pipeline of new medicines. - PE/Valuation Status: With a PE ratio roughly in line with the industry average, Eli Lilly's valuation can be considered fair, neither expensive nor cheap. Note: The provided data does not include specific financial metrics such as Net Income growth rates or exact PE ratios, which would be necessary for a comprehensive fundamental analysis.